Recombinant Rat Pde1c Protein ，His

PDE1C, or phosphodiesterase 1C, is a crucial enzyme that plays a significant role in the regulation of intracellular signaling pathways by hydrolyzing cyclic AMP (cAMP) and cyclic GMP (cGMP), two important second messengers in various physiological processes. Research on PDE1C has garnered attention due to its involvement in diverse cellular functions, including neurotransmission, cardiovascular regulation, and cell proliferation. Dysregulation of PDE1C activity has been linked to several pathological conditions, such as heart disease, cancer, and neurodegenerative disorders. The production of recombinant PDE1C protein has become an essential tool in studying its enzymatic properties, interaction with inhibitors, and biological functions. Utilizing techniques such as molecular cloning and expression systems, researchers can generate large quantities of purified PDE1C for biochemical assays and structural studies. This recombinant protein allows scientists to explore its role in drug discovery, particularly in designing selective inhibitors that may offer therapeutic benefits in diseases associated with abnormal PDE1C activity. Furthermore, the characterization of PDE1C can lead to a deeper understanding of the intricate signaling networks that govern cell behavior and how these pathways can be manipulated for therapeutic interventions. Overall, the study of recombinant PDE1C protein is vital for elucidating its biological significance and potential as a drug target in various clinical settings.